AstraZeneca backs AI-based lung cancer diagnosis pilot in UK
pharmaphorum
JANUARY 17, 2023
Greater Manchester has been selected as the site for the trial, as rates of lung cancer there are among the highest in the UK, said the partners. qXR has been trained on more than 2 million X-rays and their corresponding radiology reports, using deep-learning algorithms to interpret the images. The pilot will run for six months.
Let's personalize your content